BMPR2 and pulmonary arterial hypertension: Additionally, in a 2019 study, examining 263 PAH and PVOD/PCH patients (paediatric and adult cases), TBX4 mutations were the second most frequent mutations after BMPR2 in both paediatric and adult cases [114].